Engelsk

Eligibility Criteria

9 Formulär  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, race, gender, whether genotyping is performed, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR), version with Chronic Kidney Disease in Children Cohort (CKiD)" project.
    3. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR), version with Chronic Kidney Disease in Children Cohort (CKiD)" project.
    4. Subject ID, subject source, source subject ID, and consent group of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR)" project.
    5. Subject ID, sample ID, sample use, and study accession ID of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR)" project.
    6. Subject ID, race, country of residence, whether genotyping is performed, sex, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study" project.
    7. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study" project.
    8. Subject ID, country of residence, whether genotyping is performed, gender, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) Trial" project.
    9. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of samples obtained from participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) Trial" project.
Inclusion and exclusion criteria
Beskrivning

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
The PediGFR utilized de-identified data from subjects who had consented for genetic testing, provided a sample of DNA, and who had data available for the renal trait phenotype as well and RBC trait and anemia phenotype. Exclusions are those who did not provide genetic consent, subject IDs whose genotyping did not pass quality control.
Beskrivning

Elig.phs000842.v2.p1.1

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3242136
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C1320549
UMLS CUI [1,4]
C0370003
UMLS CUI [1,5]
C0012854
UMLS CUI [1,6]
C4035953
UMLS CUI [1,7]
C0031437
UMLS CUI [1,8]
C0232804
UMLS CUI [1,9]
C0014792
UMLS CUI [1,10]
C0002871
UMLS CUI [2,1]
C0680251
UMLS CUI [2,2]
C0021430
UMLS CUI [2,3]
C0332268
UMLS CUI [2,4]
C1285573
UMLS CUI [2,5]
C0034378
Tillbaka till toppen

Similar models

Eligibility Criteria

9 Formulär
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, race, gender, whether genotyping is performed, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR), version with Chronic Kidney Disease in Children Cohort (CKiD)" project.
    3. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR), version with Chronic Kidney Disease in Children Cohort (CKiD)" project.
    4. Subject ID, subject source, source subject ID, and consent group of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR)" project.
    5. Subject ID, sample ID, sample use, and study accession ID of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR)" project.
    6. Subject ID, race, country of residence, whether genotyping is performed, sex, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study" project.
    7. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study" project.
    8. Subject ID, country of residence, whether genotyping is performed, gender, child primary diagnosis, height, weight, tanner stage, and laboratory tests of participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) Trial" project.
    9. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of samples obtained from participants with or without chronic kidney disease and involved in the "Pediatric Investigation for Genetic Factors Linked with Renal Disease Progression (PediGFR), version with Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) Trial" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000842.v2.p1.1
Item
The PediGFR utilized de-identified data from subjects who had consented for genetic testing, provided a sample of DNA, and who had data available for the renal trait phenotype as well and RBC trait and anemia phenotype. Exclusions are those who did not provide genetic consent, subject IDs whose genotyping did not pass quality control.
boolean
C3242136 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1320549 (UMLS CUI [1,3])
C0370003 (UMLS CUI [1,4])
C0012854 (UMLS CUI [1,5])
C4035953 (UMLS CUI [1,6])
C0031437 (UMLS CUI [1,7])
C0232804 (UMLS CUI [1,8])
C0014792 (UMLS CUI [1,9])
C0002871 (UMLS CUI [1,10])
C0680251 (UMLS CUI [2,1])
C0021430 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
C1285573 (UMLS CUI [2,4])
C0034378 (UMLS CUI [2,5])
Tillbaka till toppen